Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sivagurunathan Sutharsan

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
BMC Pulmonary Medicine|April 13, 2019
Use of ivacaftor in late diagnosed cystic fibrosis monozygotic twins heterozygous for F508del and R117H-7T - a case reportMatthias Welsner, Svenja Straßburg, Christian Taube, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|July 24, 2024
Exacerbations of bronchiectasisAlessandro De Angelis, Emma D Johnson, Sivagurunathan Sutharsan, et al.
BMC Pulmonary Medicine|June 14, 2020
An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosaSivagurunathan Sutharsan, Susanne Naehrig, Uwe Mellies, et al.
BMC Pulmonary Medicine|July 3, 2024
Case Series: Hyperbilirubinemia under elexacaftor/tezacaftor/ivacaftor in the presence of Gilbert's syndromeJulia Weitzel, Matthias Welsner, Christian Taube, et al.
The Open Respiratory Medicine Journal|January 8, 2020
Changes in Clinical Markers During A Short-Term Transfer Program of Adult Cystic Fibrosis Patients from Pediatric to Adult CareMatthias Welsner, Sivagurunathan Sutharsan, Christian Taube, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 27, 2025
Advancements in monitoring paranasal sinuses among people with cystic fibrosis using photon-counting CTMarko Frings, Abdullatif Kocak, Sivagurunathan Sutharsan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 25, 2021
Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosisDirk Westhölter, Hendrik Beckert, Svenja Straßburg, et al.
BMC Pulmonary Medicine|June 1, 2023
How personality influences health outcomes and quality of life in adult patients with cystic fibrosisUte Niehammer, Svenja Straßburg, Sivagurunathan Sutharsan, et al.
Health and Quality of Life Outcomes|October 6, 2022
Cough suppression and HRQoL in adult people with cystic fibrosis: an unexplored correlationUte Niehammer, Mathis Steindor, Svenja Straßburg, et al.
Frontiers in Pharmacology|May 25, 2023
Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosisMargarete Olivier, Alexandra Kavvalou, Matthias Welsner, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
BMC Pulmonary Medicine|April 13, 2019
Use of ivacaftor in late diagnosed cystic fibrosis monozygotic twins heterozygous for F508del and R117H-7T - a case reportMatthias Welsner, Svenja Straßburg, Christian Taube, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|July 24, 2024
Exacerbations of bronchiectasisAlessandro De Angelis, Emma D Johnson, Sivagurunathan Sutharsan, et al.
BMC Pulmonary Medicine|June 14, 2020
An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosaSivagurunathan Sutharsan, Susanne Naehrig, Uwe Mellies, et al.
BMC Pulmonary Medicine|July 3, 2024
Case Series: Hyperbilirubinemia under elexacaftor/tezacaftor/ivacaftor in the presence of Gilbert's syndromeJulia Weitzel, Matthias Welsner, Christian Taube, et al.
The Open Respiratory Medicine Journal|January 8, 2020
Changes in Clinical Markers During A Short-Term Transfer Program of Adult Cystic Fibrosis Patients from Pediatric to Adult CareMatthias Welsner, Sivagurunathan Sutharsan, Christian Taube, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 27, 2025
Advancements in monitoring paranasal sinuses among people with cystic fibrosis using photon-counting CTMarko Frings, Abdullatif Kocak, Sivagurunathan Sutharsan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 25, 2021
Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosisDirk Westhölter, Hendrik Beckert, Svenja Straßburg, et al.
BMC Pulmonary Medicine|June 1, 2023
How personality influences health outcomes and quality of life in adult patients with cystic fibrosisUte Niehammer, Svenja Straßburg, Sivagurunathan Sutharsan, et al.
Health and Quality of Life Outcomes|October 6, 2022
Cough suppression and HRQoL in adult people with cystic fibrosis: an unexplored correlationUte Niehammer, Mathis Steindor, Svenja Straßburg, et al.
Frontiers in Pharmacology|May 25, 2023
Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosisMargarete Olivier, Alexandra Kavvalou, Matthias Welsner, et al.
Pageof 8